Publication for COL11A1 and POSTN

Species	Symbol	Function*	Entrez Gene ID*	Other ID	Gene coexpression	CoexViewer
hsa	COL11A1	collagen type XI alpha 1 chain	1301			[link]
hsa	POSTN	periostin	10631

Pubmed ID	Priority	Text
26348314	0.97	POSTN, TIMP3, and COL11A1) (Fig. 1C) as part of a 10-gene signature of poor survival in EOC and observed their upregulated levels in metastatic EOC in comparison to primary EOC.
	0.97	POSTN, TIMP3, and COL11A1, are enriched in the stromal rather than the epithelial tumor component during EOC progression, with the highest levels found in recurrent tumors.
	0.92	POSTN, FAP, TIMP3, CTSK, TNFAIP6, and CXCL14) are among the top ranked genes in the 200-gene signature of suboptimal debulking identified by Riester, and three (FAP, TIMP3, and COL11A1) are present in the 38-gene signature of residual disease identified by Tucker.
	0.90	POSTN, FAP, TIMP3, and COL11A1) increase proportionally with an increase in the amount of residual disease in both the TCGA and GSE9891 datasets (Fig. S1).
30542454	0.97	POSTN, COL3A1, COL1A1, COL1A2, CTSK, ITGB4, TIMP1, ITGA11, COL11A1, MYBL2, KPNA2, AURKA, TPX2 and CDC20) were identified as hub genes in smoking-associated lung cancer.
	0.97	POSTN expression were shorter compared with those with low POSTN expression, and the same trends were identified for COL3A1, COL1A1, COL1A2, CTSK, ITGB4, TIMP1, ITGA11, COL11A1, MYBL2, KPNA2, AURKA, TPX2 and CDC20.
	0.53	POSTN, (G) COL11A1, (H) TPX2, (I) COL3A1, (J) TIMP1, (K) DNALI1, (L) DNAH6, (M) CTSK, (N) DYNC2H1, (O) DNAH12 and (P) WDR78, on the survival of lung cancer patients.
24218511	0.97	COL11A1, COL5A1, COL6A2, LOX, POSTN, SNAI2, THBS2, TIMP3, VCAN) that is associated with poor overall survival in patients with high-grade serous ovarian cancer.
	0.90	COL11A1, COL5A1, COL6A2, LOX, POSTN, SNAI2, THBS2, TIMP3, VCAN) are known to be localized in the extracellular matrix and are involved in cell adhesion and collagen remodeling (Table 1).
30237810	0.97	POSTN, SPARC, COL1A1, COL5A1, COL5A2, COL10A1 and COL11A1.
29928392	0.96	COL11A1 could interact with the osteoblast-specific factor periostin (POSTN), although this requires further experimental validation.
	0.94	COL11A1, collagen type XI alpha I; COL3A1, collagen type III alpha 1; POSTN, periostin.
	0.93	COL11A1, TOX high mobility group box family member 3, NQO1 and POSTN, no experimental evidence could be obtained.
	0.90	POSTN, periostin; COL11A1, collagen type XI alpha I; COL3A1, collagen type III alpha 1; TOX3, TOX high mobility group box family member 3; CLDN3, claudin 3; CEBPA, CCAAT/enhancer binding protein (C/EBP) alpha.
19145252	0.96	periostin (POSTN), thrombospondin-1 (THBS1), cartilage linking protein-1 (CRTL-1), and collagen type I (COL1A1), collagen type V (COL5A1), and collagen type XI (COL11A1).
24086345	0.96	COL11A1, COL3A1, MMP2, POSTN, SPARC, DST and THBS2, produced high number of RPKM and positively correlated with the gene expression array data (Figure 6 C).
27467239	0.96	COL11A1, COL13A1, POSTN, but also other relevant genes such as TGFB2, ITGA10 and WISP1.
30734283	0.95	COL11A1, collagen type XI alpha 1 chain; TNC, tenascin-C; PDGFRalpha/beta, platelet derived growth factor receptor alpha/beta; VIM, vimentin; S100A4 (FSP1), S100 calcium-binding protein A4; POSTN, periostin; EPCAM, epithelial cell adhesion molecule; KRT20, keratin 20; WNT7a, Wnt family member 7A; PDGF, platelet derived growth factor; SHH, sonic hedgehog; IL1beta, interleukin 1beta; TGF-beta, transforming growth factor beta; IL17A, interleukin 17A; WNT10b, Wnt family member 10B; WNT2, Wnt family member 2; IGF2, insulin like growth factor 2; CXCL6, C-X-C motif chemokine ligand 6; HGF, hepatocyte growth factor; IL11, interleukin 11; MMPs, matrix metalloproteinases; IL6, Interleukin 6; SDF-1, stromal cell-derived factor 1; CXCL1, chemokine (C-X-C motif) ligand 1. [Color figure can be viewed at http://wileyonlinelibrary.com]
27806724	0.93	COL11A1, COL5A1, COL6A2, LOX, POSTN, SNAI2, THBS2, TIMP3, and VCAN) has been validated to be associated with poor overall survival in patients with high-grade serous ovarian cancer.
26087191	0.92	POSTN, INHBA, THBS2, COL11A1, and Twist1 mRNA levels were evaluated by real-time RT-PCR in A2780, A2780CP70, ov2008, and ov2008CP20 ovarian cancer cells.
	0.89	POSTN, COL11A1, INHBA, TWIST1, and THBS2) were selected and real-time RT-polymerase chain reaction (PCR) data both confirmed the reliability of our expression data and identified COL11A1 as the most highly elevated transcript linked to chemoresistance, with an 8-fold increase compared to that of the control.
32027093	0.92	POSTN, APOE, MMP9, S100A4, COL1A2, COL3A1, VCAN, COL11A1, SDC1, LAMB1 and FN1) were detected by hub gene analysis and module analysis simultaneously.
17411443	0.89	POSTN, COL4A1, COL11A1, COL1A2 and COL5A2.
24796616	0.83	COL11A1, COL5A1, COL6A2, LOX, POSTN, SNAI2, THBS2, TIMP3, VCAN) in primary ovarian tumors correlates with metastasis, recurrence and poor survival.
30236106	0.82	POSTN, THBS2, PLEKHC1, COL11A1 and FAP, which have already been associated with tumour progression/invasion.
28289080	0.76	COL11A1, COL5A1, COL6A2, LOX, POSTN, SNAI2, THBS2, TIMP3 and VCAN) were identified as associated with poor overall survival.
30458865	0.72	collagenase 11A1 (COL11A1), Asporin (ASPN) and Periostin (POSTN), were reported in four studies as having lower abundance in involved LNs compared to primary tumour tissue.
26030917	0.69	COL11A1, COL10A1, COL8A1, FAP, FABP4, POSTN), thus generating a dataset OT of dimension 161 samples and 20 features.